—Researchers recently examined how different iron chelation medications—deferoxamine, deferiprone, and deferasirox—impacted iron stores and long-term health in patients with transfusion-dependent ...

Hemochromatosis is one of the most common genetic conditions and can be life-threatening — here's how it manifests.

Starting iron chelation therapy early may prevent growth problems and organ damage from iron overload in children with TDT. Currently approved medications have limitations for use in very young ...

Heavy metals are dangerous at high levels, but treatments that remove can also be risky and only benefit certain patients.

Patients on dopaminergic agonists (n, mean daily L-dopa equivalent in mg) 18 (243) 18 (220) 4 (225) 13 (250) Patients on L-dopa and agonists (n) 7 7 2 5 Cognition and behavior: MDS-UPDRS part I score ...

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.

Thalassemia patients in Kerala face falling haemoglobin levels due to shortage of leukocyte filters and iron chelation drugs.

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Iron Overload Syndrome Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...